Pioglitazone inhibits oxidative stress, MMP-mediated inflammation and vascular dysfunction in high glucose-induced human saphenous vein grafts.

MLA

Onursal, Ceylan, et al. “Pioglitazone Inhibits Oxidative Stress, MMP-Mediated Inflammation and Vascular Dysfunction in High Glucose-Induced Human Saphenous Vein Grafts.” Journal of Diabetes and Its Complications, vol. 37, no. 4, Apr. 2023, p. 108421. EBSCOhost, https://doi.org/10.1016/j.jdiacomp.2023.108421.

APA

Onursal, C., Reel, B., Bintepe, C., Guzeloglu, M., Ersoy, N., & Bagriyanik, A. (2023). Pioglitazone inhibits oxidative stress, MMP-mediated inflammation and vascular dysfunction in high glucose-induced human saphenous vein grafts. Journal of Diabetes and Its Complications, 37(4), 108421. https://doi.org/10.1016/j.jdiacomp.2023.108421

Chicago

Onursal, Ceylan, Buket Reel, Caglar Bintepe, Mehmet Guzeloglu, Nevin Ersoy, and Alper Bagriyanik. 2023. “Pioglitazone Inhibits Oxidative Stress, MMP-Mediated Inflammation and Vascular Dysfunction in High Glucose-Induced Human Saphenous Vein Grafts.” Journal of Diabetes and Its Complications 37 (4): 108421. doi:10.1016/j.jdiacomp.2023.108421.